Safety and Efficacy of Inpatient Diabetes Management with Non-insulin Agents: an Overview of International Practices.
Rodolfo J GalindoKetan DhatariyaFernando Gomez-PeraltaGuillermo E UmpierrezPublished in: Current diabetes reports (2022)
Several observational and prospective randomized controlled studies have demonstrated that oral anti-hyperglycemic agents are widely used in the hospital, including studies of DPP-4 agents and GLP-1 agonists. With advances in the field of inpatient diabetes management, a paradigm shift has occurred, from an approach of recommending "basal-bolus regimens" for all patients to a more precision medicine option for hospitalized non-critically ill patients with type 2 diabetes.
Keyphrases
- type diabetes
- glycemic control
- end stage renal disease
- cardiovascular disease
- healthcare
- acute care
- palliative care
- chronic kidney disease
- newly diagnosed
- mental health
- primary care
- ejection fraction
- peritoneal dialysis
- open label
- prognostic factors
- double blind
- emergency department
- clinical trial
- patient reported outcomes
- phase iii
- metabolic syndrome
- phase ii